VET (VET) Stock Price & Analysis

VET (VET) fell 4.30% to USD 11.12 as of June 10, 2026 at 00:29 UTC, according to Nexqual real-time market data.

VET last closed at USD 11.62; the session ranged USD 10.91–11.49 on volume of 1,223,531 shares. Market capitalization is $1.70B, with a 52-week range of USD 7–14.82 (NYQ). Source: Nexqual, June 10, 2026 at 00:29 UTC.

Key Statistics (as of June 10, 2026 at 00:29 UTC)

PriceUSD 11.12
Change▼ 4.30% (down)
Previous CloseUSD 11.62
OpenUSD 11.47
Day RangeUSD 10.91 – 11.49
52-Week RangeUSD 7 – 14.82
Volume1,223,531 shares
Market Cap$1.70B
ExchangeNYQ

Technical Analysis (VET)

Nexqual's technical model rates VET "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:29 UTC.

Overall SignalSELL
RSI (14)39.59 (neutral)
vs SMA50Below (USD 12.47)
MACD-0.3 (negative)

Analyst Ratings (VET)

Wall Street analysts rate VET "Buy", per Nexqual as of June 10, 2026 at 00:29 UTC.

Consensus RatingBuy
Buy / Hold / Sell4 / 6 / 0

Earnings (VET)

Next Earnings Date2026-08-06
Revenue Estimate$469.30M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.92 vs est 0.27 ▼ miss
2025-12-31USD -2.86 vs est 0.08 ▼ miss
2025-09-30USD 0.02 vs est 0.19 ▼ miss
2025-06-30USD 0.48 vs est -0.14 ▲ beat

Source: Nexqual, June 10, 2026 at 00:29 UTC.

Financials & Fundamentals (VET)

Total Revenue$1.75B
Revenue Growth (YoY)+9.90%
Gross Margin+61.36%
Operating Margin-41.46%
Profit Margin-46.65%
ROE-20.70%
Debt / Equity64.14
Current Ratio0.63
Total Cash$16.35M
Total Debt$1.31B
Free Cash Flow$269.56M

Source: Nexqual, June 10, 2026 at 00:29 UTC.

Financial Health Score (VET)

Nexqual rates VET's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:29 UTC.

GrowthMixed — Revenue +2.5% YoY (annual), slow
ProfitabilitySolid — Gross margin 61%, operating -41%
Balance SheetMixed — $16M cash vs $1.31B debt
Cash FlowSolid — FCF $270M, 13% margin
EfficiencyCritical — ROE -21%, ROA 1.3%

Ownership (VET)

Insider Ownership+0.23%
Institutional Ownership+63.30%
Shares Outstanding153.20M
Float151.76M

Source: Nexqual, June 10, 2026 at 00:29 UTC.

Leadership (VET)

VET is led by Anthony Hatcher P.Eng. (age 52), President, CEO & Director, per Nexqual as of June 10, 2026 at 00:29 UTC.

President, CEO & DirectorAnthony Hatcher P.Eng. (age 52)
VP & CFOLars William Glemser
Vice President of International & HSEDarcy Kerwin P.Eng.
Vice President of North AmericaLee Ernest McQuaig P.Eng.
Vice President of Business DevelopmentLarissa Marianne Conrad P.Eng.

Major Backers & Investors (VET)

Notable institutional backers of VET include American Century Companies Inc, Morgan Stanley, Ameriprise Financial, Inc., according to Nexqual as of June 10, 2026 at 00:29 UTC.

Active Investors

InvestorStake
American Century Companies Inc5.09%
Morgan Stanley3.83%
Ameriprise Financial, Inc.3.42%
Millennium Management3.31%
Mackenzie Financial Corporation2.85%
UBS Group AG2.1%
LM Asset Management, Inc2.06%

Index Funds (Passive)

FundStake
Vanguard Group5.27%
Columbia Threadneedle3.68%
Dimensional Fund Advisors3.58%

Source: Nexqual, June 10, 2026 at 00:29 UTC.

Peers & Related Stocks

SymbolNamePriceChange
CVECenovus Energy IncUSD 27.65▼ 2.02%
OVVOvintiv Inc. (DE)USD 56.59▼ 0.19%
VET.TOVERMILION ENERGY INCCAD 15.48▼ 2.27%
ARAntero Resources CorporationUSD 34.66▼ 2.53%
KOSKosmos Energy Ltd.USD 2.79▼ 0.71%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:29 UTC. This page is informational and not investment advice.